Home / Stocks / PRLD

PRLD insider trading

Prelude Therapeutics Inc — open-market insider buys and $1M+ sells from SEC Forms 3, 4 and 5.
Insider buys · 24 mo
12
Bought · 24 mo
$25.9M
Buys · last 90 days
0 · $0
Most recent buy
2026-04-23

Cluster buy detected

3 insiders bought PRLD within a short window (2024-12-18→2024-12-31), $226k in total — cluster score 60/100. Members see the buyers, the score breakdown and the chart.

See the cluster

Recent insider filings

FiledInsiderTypeSharesPriceValue
2026-04-23Bonita David P
Director · 10% owner
Bought2,815,315$4.44$12.5M
2026-04-23ORBIMED ADVISORS LLC
Director · 10% owner
Bought2,815,315$4.44$12.5M
2025-03-27Combs Andrew
Chief Chemistry Officer
Bought100,000$0.69$69k
2025-03-27Vaddi Krishna
CEO
Bought675,000$0.69$466k
2025-03-24Vaddi Krishna
CEO
Bought20,416$0.73$15k
2025-03-18Vaddi Krishna
CEO
Bought39,105$0.75$29k
2025-03-14Vaddi Krishna
CEO
Bought97,500$0.72$70k
2025-01-03Vaddi Krishnacluster
CEO
Bought5,000$1.21$6k
2025-01-02Vaddi Krishnacluster
CEO
Bought10,000$1.20$12k
2024-12-26Combs Andrewcluster
Chief Chemistry Officer
Bought63,075$1.36$86k
2024-12-20Vaddi Krishnacluster
CEO
Bought106,888$0.93$99k
2024-12-20Lim Bryant Davidcluster
CLO, Interim CFO, Corp Sec.
Bought25,000$0.91$23k

Most active insider buyers

InsiderRoleBuysTotal bought
Bonita David PDirector · 10% owner1$12.5M
ORBIMED ADVISORS LLCDirector · 10% owner1$12.5M
Vaddi KrishnaCEO7$697k
Combs AndrewChief Chemistry Officer2$155k
Lim Bryant DavidCLO, Interim CFO, Corp Sec.1$23k

See PRLD on the chart

Every insider buy and sell for PRLD plotted on the price, the full two-year history, cluster scores and daily updates — in the members area, $29/month. A free quarterly sample of the whole dataset needs no account.

Open the browserFree sample
Data from the SEC EDGAR ownership filings, refreshed daily. Only open-market purchases (transaction code P) and sales of $1M or more are shown; grants, option exercises and tax withholding are excluded because they run on schedules set years earlier. Not investment advice.